- Home
- NTWK vs OTLK Comparison
NTWK vs OTLK Comparison
Compare NTWK & OTLK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTWK
- OTLK
- Stock Information
- Founded
- NTWK 1997
- OTLK 2010
- Country
- NTWK United States
- OTLK United States
- Employees
- NTWK N/A
- OTLK N/A
- Industry
- NTWK Computer Software: Prepackaged Software
- OTLK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NTWK Technology
- OTLK Health Care
- Exchange
- NTWK Nasdaq
- OTLK Nasdaq
- Market Cap
- NTWK 31.1M
- OTLK 33.6M
- IPO Year
- NTWK 1998
- OTLK 2016
- Fundamental
- Price
- NTWK $2.68
- OTLK $2.09
- Analyst Decision
- NTWK
- OTLK Strong Buy
- Analyst Count
- NTWK 0
- OTLK 6
- Target Price
- NTWK N/A
- OTLK $23.08
- AVG Volume (30 Days)
- NTWK 28.7K
- OTLK 1.2M
- Earning Date
- NTWK 02-11-2025
- OTLK 02-12-2025
- Dividend Yield
- NTWK N/A
- OTLK N/A
- EPS Growth
- NTWK N/A
- OTLK N/A
- EPS
- NTWK 0.06
- OTLK N/A
- Revenue
- NTWK $61,749,408.00
- OTLK N/A
- Revenue This Year
- NTWK N/A
- OTLK N/A
- Revenue Next Year
- NTWK N/A
- OTLK $603.93
- P/E Ratio
- NTWK $41.84
- OTLK N/A
- Revenue Growth
- NTWK 14.50
- OTLK N/A
- 52 Week Low
- NTWK $1.99
- OTLK $0.87
- 52 Week High
- NTWK $3.34
- OTLK $12.85
- Technical
- Relative Strength Index (RSI)
- NTWK 51.07
- OTLK 44.67
- Support Level
- NTWK $2.62
- OTLK $2.01
- Resistance Level
- NTWK $2.73
- OTLK $2.31
- Average True Range (ATR)
- NTWK 0.10
- OTLK 0.26
- MACD
- NTWK 0.01
- OTLK 0.09
- Stochastic Oscillator
- NTWK 50.00
- OTLK 36.08
About NTWK NetSol Technologies Inc. Common Stock
NETSOL Technologies Inc is involved in providing information technology and enterprise software solutions. Its products and services include NFS Ascent, NFS Digital, Leasepak Cloud, Business consultancy, and information security services among others. The firm has North America, Europe, and Asia-Pacific segments, of which the majority of the revenue is derived from Asia-Pacific. It derives revenue from licensing, customization, enhancements, and maintenance of its financial applications. The company promotes and sells its products under the Netsol financial suite.
About OTLK Outlook Therapeutics Inc.
Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications.